PATENT CLAIM ANALYSIS

Application Number: 15749469
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "472000"]

Abstract:
The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone or pharmaceutical acceptable salt thereof in the form of a multi-layer tablet that provides zero order drug release. It also relates to a process for the preparation thereof.

Claim (Index 3):
The controlled release tablet of  claim 2 , wherein the hydrophilic polymer comprises one of HPMC, HPC, HEC, carrageenan, sodium alginate, xanthan gum and the hydrophobic polymer comprises one of ethyl cellulose, polyvinyl alcohol, HPMC acetate succinate, methacrylic acid copolymers containing low level of quaternary ammonium groups.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.20513
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15423388', '15210760', '15624209', '13634476', '15424134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7494975344388333
- 35 USC 102 Novelty (BERT): 0.488022040306149
- Combined Prediction Score: 0.7233499850255648
- Mean Citation Score: 223.681358
- Max Citation Score: 226.62735
- Similarity Product: 176.7878325346291

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test